formula | C_37H_67NO_13 name | erythromycin IUPAC name | 6-(4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl)oxy-14-ethyl-7, 12, 13-trihydroxy-4-(5-hydroxy-4-methoxy-4, 6-dimethyl-oxan-2-yl)oxy-3, 5, 7, 9, 11, 13-hexamethyl-1-oxacyclotetradecane-2, 10-dione
molar mass | 733.9 g/mol phase | solid (at STP) melting point T_m | 138 °C mass density | 1.226 g/cm^3
experimental LogP hydrophobicity | 3.06 predicted LogP hydrophobicity | 2.37 predicted LogS | -3.2 experimental Caco-2 permeability | -5.43
acenocoumarol | alfentanil | alprazolam | aminophylline | amiodarone | anisindione | aprepitant | astemizole | atorvastatin | bretylium | ... (total: 81)
approval status | approved | small molecule drug categories | anti-bacterial agent dosage forms | oral: capsule, coated | dental: liquid | oral: liquid | ophthalmic: ointment | intravenous: powder | oral: powder | intravenous: powder, for solution | oral: powder, for solution | oral: powder, for suspension | oral: suspension | oral: tablet
mass density | 1.226 g/cm^3
CAS registry number | 114-07-8 Beilstein number | 75279 PubChem compound ID | 3255 PubChem substance ID | 5020 SMILES identifier | CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
